Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel V T Catenacci

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Seminars in Oncology|March 23, 2011
Personalized colon cancer care in 2010Daniel V T Catenacci, Mark Kozloff, Hedy L Kindler, et al.
Journal of Human Genetics|August 1, 2009
A survey of the population genetic variation in the human kinomeWei Zhang, Daniel V T Catenacci, Shiwei Duan, et al.
The Oncologist|November 25, 2018
Initial Report of Second-Line FOLFIRI in Combination with Ramucirumab in Advanced Gastroesophageal Adenocarcinomas: A Multi-Institutional Retrospective AnalysisSamuel J Klempner, Steven B Maron, Leah Chase, et al.
Gastroenterology|September 6, 2015
Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic UltrasoundDaniel V T Catenacci, Christopher G Chapman, Peng Xu, et al.
JCO Clinical Cancer Informatics|August 1, 2019
Obtaining Knowledge in Pathology Reports Through a Natural Language Processing Approach With Classification, Named-Entity Recognition, and Relation-Extraction HeuristicsTomasz Oliwa, Steven B Maron, Leah M Chase, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2020
Spatial and Temporal Heterogeneity of PD-L1 Expression and Tumor Mutational Burden in Gastroesophageal Adenocarcinoma at Baseline Diagnosis and after ChemotherapyKatherine I Zhou, Bryan Peterson, Anthony Serritella, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2016
Therapeutically Induced Changes in HER2, HER3, and EGFR Protein Expression for Treatment GuidanceShankar Sellappan, Adele Blackler, Wei-Li Liao, et al.
Investigational New Drugs|March 20, 2016
A phase 1 clinical trial of ASG-5ME, a novel drug-antibody conjugate targeting SLC44A4, in patients with advanced pancreatic and gastric cancersAndrew L Coveler, Andrew H Ko, Daniel V T Catenacci, et al.
Cancer Discovery|March 6, 2012
Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrenceDaniel V T Catenacci, Les Henderson, Shu-Yuan Xiao, et al.
Cancer|December 8, 2016
MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinomaDaniel V T Catenacci, Agnes Ang, Wei-Li Liao, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Seminars in Oncology|March 23, 2011
Personalized colon cancer care in 2010Daniel V T Catenacci, Mark Kozloff, Hedy L Kindler, et al.
Journal of Human Genetics|August 1, 2009
A survey of the population genetic variation in the human kinomeWei Zhang, Daniel V T Catenacci, Shiwei Duan, et al.
The Oncologist|November 25, 2018
Initial Report of Second-Line FOLFIRI in Combination with Ramucirumab in Advanced Gastroesophageal Adenocarcinomas: A Multi-Institutional Retrospective AnalysisSamuel J Klempner, Steven B Maron, Leah Chase, et al.
Gastroenterology|September 6, 2015
Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic UltrasoundDaniel V T Catenacci, Christopher G Chapman, Peng Xu, et al.
JCO Clinical Cancer Informatics|August 1, 2019
Obtaining Knowledge in Pathology Reports Through a Natural Language Processing Approach With Classification, Named-Entity Recognition, and Relation-Extraction HeuristicsTomasz Oliwa, Steven B Maron, Leah M Chase, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2020
Spatial and Temporal Heterogeneity of PD-L1 Expression and Tumor Mutational Burden in Gastroesophageal Adenocarcinoma at Baseline Diagnosis and after ChemotherapyKatherine I Zhou, Bryan Peterson, Anthony Serritella, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2016
Therapeutically Induced Changes in HER2, HER3, and EGFR Protein Expression for Treatment GuidanceShankar Sellappan, Adele Blackler, Wei-Li Liao, et al.
Investigational New Drugs|March 20, 2016
A phase 1 clinical trial of ASG-5ME, a novel drug-antibody conjugate targeting SLC44A4, in patients with advanced pancreatic and gastric cancersAndrew L Coveler, Andrew H Ko, Daniel V T Catenacci, et al.
Cancer Discovery|March 6, 2012
Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrenceDaniel V T Catenacci, Les Henderson, Shu-Yuan Xiao, et al.
Cancer|December 8, 2016
MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinomaDaniel V T Catenacci, Agnes Ang, Wei-Li Liao, et al.
Pageof 7